Rosetta Inpharmatics LLC

Description

Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co. Inc., develops and implements technologies that will improve drug discovery. The company's leading-edge genomic research and data analysis efforts focus on how medical compounds affect biology, enabling more accurate selection of drug targets and more efficient drug development.Rosetta Inpharmatics was founded in 1996 to design and implement DNA microarray gene expression technologies. The company was established with the goal to overcome the problems limiting the discovery and effective development of pharmaceutical and agricultural products. The founders include: Stephen H. Friend, M.D., Ph.D., the company's president; Leland Hartwell, Ph.D., and Leroy Hood, M.D., Ph.D. Rosetta Inpharmatics' technology and patent portfolio were enhanced by its purchase of Acacia Biosciences, Inc. in February 1999, a company founded by Jasper Rine, Ph.D.In October 1999, the Company signed a strategic partnership agreement with Agilent Technologies to further develop and commercialize Rosetta Inpharmatics' DNA microarrays. As part of this agreement, Agilent made a significant equity investment in Rosetta Inpharmatics.

Fact sheet

Companies nearby